Continuous Renal Replacement Therapy Market – Overview
This report on the global continuous renal replacement therapy market analyzes the current and future scenario of the global market. Increasing prevalence of acute kidney injury, increasing government initiatives to deal with acute renal failure, and rising geriatric population all over the world are projected to drive the growth of the market during the forecast period.
The global continuous renal replacement therapy market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on mode, product, therapy, end-user, and geography. A detailed qualitative analysis of drivers and restraints, opportunities and trends has been provided in the market overview section. Additionally, the section comprises market merger and acquisition deals to help understand the scope of the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global continuous renal replacement therapy market.
The global continuous renal replacement therapy market has been classified on the basis of mode, product, therapy, end-user, and region. Based on mode, the market has been categorized into slow continuous ultrafiltration, continuous veno venous haemo-filtration, continuous veno venous haemo-dialysis, and continuous veno venous haemo-dia-filtration. In terms of product, the market has been classified into dialysate and replacement fluids, disposables, and systems. Disposables can further be divided into bloodline sets, haemo-filters, and other disposables. Based on therapy, the market has been segmented into renal, non-renal, and combination of both. In terms of end-user, the market has been categorized into hospitals, clinics, and homes.
Geographically, the global continuous renal replacement therapy market has been categorized into five major regions and a key countries in the respective region: North America (the U.S and Canada), Europe (Germany, France, Italy, Spain, U.K, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, and Rest of Middle East &Africa).
The report also profiles major players in the global continuous renal replacement therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Bellco, NxStage Medical, Inc., and other prominent players.
The global continuous renal replacement therapy market has been segmented as below:
Global continuous renal replacement therapy market, by mode
- Slow Continuous Ultra filtration
- Continuous Veno Venous Haemo-filtration
- Continuous Veno Venous Haemo-dialysis
- Continuous Veno Venous Haemo-diafiltration
Global continuous renal replacement therapy market, by product
- Dialysate and Replacement Fluids
- Bloodline sets
- Other disposables
Global continuous renal replacement therapy market, by therapy
- Combination of Both
Global continuous renal replacement therapy market, by end-user
Global continuous renal replacement therapy market, by geography
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa